Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday. Like its reference ...

ORLANDO, Fla. — Using fixed-ratio insulin combinations (FRC) can reduce side effects such as nausea in treating diabetes, an advantage that should persuade clinicians to consider these drugs more ...

The new insulin, Awiqli, is cheaper than many daily insulin analogues and could ease fears of multiple injections among people with diabetes.